Sales & Marketing News | pharmaphorum

News

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development of combined flu/COVID shots in a deal worth up

News

Spectral AI nears first sales of wound care system

Spectral AI is on the brink of becoming a commercial-stage company, with the first sales of its DeepView wound imaging system due to start in its first market, the UK, lat

News

Sorcero GenAI conjures plain language from scientific papers

Understanding complex scientific studies is often a challenge for patients as well as healthcare professionals, but one that may become easier thanks to artificial intelli

News

Citi analyst Andrew Baum to head Pfizer strategy team

Pfizer will draw on the expertise of Citi analyst Andrew Baum when it comes to portfolio management and capital deployment, naming him chief strategy and innovation office

News

Novavax's chief executive John Jacobs (l) and Shah Capital's founder Himanshu Shah (r)

Activist investor urges changes to Novavax board

Shah Capital has stepped up its campaign for change at vaccine producer Novavax, lobbying against the re-election of three directors and executive pay packages in a letter

News

Wegovy sales double, as starting restrictions start to lift

Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Spectral AI nears first sales of wound care system

Sorcero GenAI conjures plain language from scientific papers

Citi analyst Andrew Baum to head Pfizer strategy team

Activist investor urges changes to Novavax board

Wegovy sales double, as starting restrictions start to lift

Astellas pays $285m for Audax cancer drug, and other deals

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks